442 related articles for article (PubMed ID: 11434771)
1. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
2. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
[TBL] [Abstract][Full Text] [Related]
3. The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.
Xu W; Campillo M; Pardo L; Kim de Riel J; Liu-Chen LY
Biochemistry; 2005 Dec; 44(49):16014-25. PubMed ID: 16331961
[TBL] [Abstract][Full Text] [Related]
4. Activation of the mu opioid receptor involves conformational rearrangements of multiple transmembrane domains.
Xu W; Sanz A; Pardo L; Liu-Chen LY
Biochemistry; 2008 Oct; 47(40):10576-86. PubMed ID: 18778083
[TBL] [Abstract][Full Text] [Related]
5. The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant.
Huang P; Visiers I; Weinstein H; Liu-Chen LY
Biochemistry; 2002 Oct; 41(40):11972-80. PubMed ID: 12356297
[TBL] [Abstract][Full Text] [Related]
6. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
Nebane NM; Hurst DP; Carrasquer CA; Qiao Z; Reggio PH; Song ZH
Biochemistry; 2008 Dec; 47(52):13811-21. PubMed ID: 19053233
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
[TBL] [Abstract][Full Text] [Related]
8. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.
Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM
Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039
[TBL] [Abstract][Full Text] [Related]
9. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
Huang P; Li J; Chen C; Visiers I; Weinstein H; Liu-Chen LY
Biochemistry; 2001 Nov; 40(45):13501-9. PubMed ID: 11695897
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
[TBL] [Abstract][Full Text] [Related]
11. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
Javitch JA; Shi L; Simpson MM; Chen J; Chiappa V; Visiers I; Weinstein H; Ballesteros JA
Biochemistry; 2000 Oct; 39(40):12190-9. PubMed ID: 11015197
[TBL] [Abstract][Full Text] [Related]
12. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
Deng HB; Guang W; Wang JB
J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
14. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.
Javitch JA; Ballesteros JA; Weinstein H; Chen J
Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
Joshi S; Lee JW; Wong YH
Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
[TBL] [Abstract][Full Text] [Related]
16. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
[TBL] [Abstract][Full Text] [Related]
17. Cysteine 2.59(89) in the second transmembrane domain of human CB2 receptor is accessible within the ligand binding crevice: evidence for possible CB2 deviation from a rhodopsin template.
Zhang R; Hurst DP; Barnett-Norris J; Reggio PH; Song ZH
Mol Pharmacol; 2005 Jul; 68(1):69-83. PubMed ID: 15840841
[TBL] [Abstract][Full Text] [Related]
18. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
Wang WW; Shahrestanifar M; Jin J; Howells RD
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
[TBL] [Abstract][Full Text] [Related]
19. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
Shi L; Simpson MM; Ballesteros JA; Javitch JA
Biochemistry; 2001 Oct; 40(41):12339-48. PubMed ID: 11591153
[TBL] [Abstract][Full Text] [Related]
20. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
